Since last fall’s triumph at the Nokia Sensing XChallenge the DNA Medicine Institute has continued its work with NASA. Under a procurement for utilization of the International Space Station, DMI will develop its rHEALTH X technology for astronaut crew member use. The rHEALTH X technology is particularly well-suited for long-duration space travel and will allow crew members to monitor their own health in an autonomous manner. The Cambridge based company has been selected for a Phase II follow-on contract in an effort to further develop the technology bringing it one step closer to space.
